CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 447 enrolled
Drug / intervention
Acetaminophen/Naproxen Sodium Fixed Combination +3 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05761574
NCT05761574Phase 3Completed

A Full-Factorial, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Single-Dose Efficacy and Safety Study of an Acetaminophen/Naproxen Sodium Fixed Combination, Acetaminophen, and Naproxen Sodium in Postoperative Dental Pain

Johnson & Johnson Consumer Inc. (J&JCI)·interventional·Posted Mar 9, 2023·Updated Jul 2, 2025

In Brief

A Phase 3 clinical trial evaluating Acetaminophen/Naproxen Sodium Fixed Combination, Naproxen Sodium, and 2 other interventions for Pain. Completed, enrolled 447 participants across 1 site.

Detailed Summary

The purpose of this study is to evaluate how well a fixed combination of acetaminophen/naproxen sodium relieves postoperative dental pain compared with acetaminophen, naproxen sodium and placebo.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPain
CountriesUnited States
Collaborators--

Timeline

Phase 3CompletedFinished
202420252026
First PostedMar 9, 2023
Enrollment StartMay 22, 2023
Primary CompletionMay 17, 2024
Study CompletionMay 30, 2024
TodayJul 2, 2026
Enrollment to primary: 12 monthsPosted 3.3 years ago

Interventions

Acetaminophen/Naproxen Sodium Fixed Combinationdrug

Fixed combination of Acetaminophen/Naproxen Sodium will be administered orally.

Naproxen Sodiumdrug

Naproxen Sodium will be administered orally.

Acetaminophendrug

Acetaminophen will be administered orally.

Placebodrug

Placebo will be administered orally.